Health Sciences Group, Inc.
HESG · OTC
9/30/2006 | 6/30/2006 | 3/31/2006 | 12/31/2005 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -35% | -62.7% | -44% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 34.9% | 27.1% | 26.3% | 23.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $0 | $1 |
| SG&A Expenses | $1 | $1 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$0 |
| Other Operating Expenses | $0 | -$3 | $0 | -$0 |
| Operating Expenses | $1 | -$2 | $2 | $1 |
| Operating Income | -$1 | $2 | -$2 | -$1 |
| % Margin | -18,430.1% | 19,742.4% | -9,891% | -2,754.4% |
| Other Income/Exp. Net | -$0 | -$3 | $0 | $1 |
| Pre-Tax Income | -$1 | -$1 | -$2 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$2 | $0 |
| % Margin | -19,219.1% | -15,352.3% | -8,173% | 63.2% |
| EPS | -0.03 | -0.04 | -0.06 | 0.001 |
| % Growth | 25% | 33.3% | -6,766.7% | – |
| EPS Diluted | -0.03 | -0.04 | -0.06 | 0.001 |
| Weighted Avg Shares Out | 40 | 33 | 28 | 25 |
| Weighted Avg Shares Out Dil | 40 | 33 | 28 | 25 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$1 | $2 | -$1 | -$0 |
| % Margin | -10,236.7% | 26,682.4% | -6,813.3% | -979.2% |